Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN)

Affiliations

• ¹ Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany. [email protected].
• ² Department of Medicine III, University Hospital Bonn, Bonn, Germany. [email protected].
• ³ Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen/Bonn, Germany. [email protected].
• ⁴ Innere Medizin C, Hämatologie und Onkologie, Universitätsmedizin Greifswald, Greifswald, Germany.
• ⁵ Innere Medizin 2, Hämatologie und Onkologie, Universitätsklinikum Jena, Jena, Germany.
• ⁶ Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany.
• ⁷ Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
• ⁸ Department of Medicine III, University Hospital Bonn, Bonn, Germany.
• ⁹ Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen/Bonn, Germany.
• ¹⁰ Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
• ¹¹ University Clinic for Hematology, Oncology, Haemostaseology and Palliative Care, Johannes Wesling Medical Center Minden, University of Bochum, Bochum, Germany.